Keenova Therapeutics plc Operating Lease Cost
Keenova Therapeutics plc reported Operating Lease Cost of $15.80 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-04-15
- Keenova Therapeutics plc operating lease, cost for the quarter ending 2019-12-27 was $5.70M.
- Keenova Therapeutics plc operating lease, cost for the quarter ending 2019-09-27 was $5.40M.
- Keenova Therapeutics plc operating lease, cost for the quarter ending 2019-06-28 was $5.30M.
- Keenova Therapeutics plc operating lease, cost for the quarter ending 2019-03-29 was $4.90M.
- Keenova Therapeutics plc operating lease, cost for fiscal 2025 was $15.80M, a 66.32% increase from fiscal 2024.
- Keenova Therapeutics plc operating lease, cost for fiscal 2024 was $9.50M.
- Keenova Therapeutics plc operating lease, cost for fiscal 2021 was $19.60M, a 7.55% decline from fiscal 2020.
- Keenova Therapeutics plc operating lease, cost for fiscal 2020 was $21.20M, a 0.47% decline from fiscal 2019.
| Period end | Operating Lease, Cost 1 month | Operating Lease, Cost 1 month as first filed | Operating Lease, Cost 3 month | Operating Lease, Cost 5 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 10 month | Operating Lease, Cost 10 month as first filed | Operating Lease, Cost 12 month | Operating Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $15.80M 10-K · filed 2026-04-15 | |||||||||
| 2024-12-27 | $9.50M 10-K · filed 2026-04-15 | $13.90M 10-K · filed 2025-03-13 | ||||||||
| 2023-12-29 | $1.40M 10-K · filed 2026-04-15 | $1.80M 10-K · filed 2024-03-26 | ||||||||
| 2023-11-14 | $9.90M 10-K · filed 2026-04-15 | $15.00M 10-K · filed 2024-03-26 | ||||||||
| 2022-12-30 | $7.90M 10-K · filed 2025-03-13 | |||||||||
| 2022-06-16 | $8.70M 10-K · filed 2025-03-13 | |||||||||
| 2021-12-31 | $19.60M 10-K · filed 2024-03-26 | |||||||||
| 2020-12-25 | $21.20M 10-K · filed 2023-03-03 | |||||||||
| 2019-12-27 | $5.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $11.10M derived: sum of 2 quarters · filed 2022-03-15 | $16.40M derived: sum of 3 quarters · filed 2022-03-15 | $21.30M 10-K · filed 2022-03-15 | ||||||
| 2019-09-27 | $5.40M 10-Q · filed 2019-11-05 | $10.70M derived: sum of 2 quarters · filed 2019-11-05 | $15.60M 10-Q · filed 2019-11-05 | |||||||
| 2019-06-28 | $5.30M 10-Q · filed 2019-08-06 | $10.20M 10-Q · filed 2019-08-06 | ||||||||
| 2019-03-29 | $4.90M 10-Q · filed 2019-05-07 |